Epidermal growth factor receptors in human breast and endometrial carcinomas.
The incidence and levels of epidermal growth factor receptor (EGFR) were studied in 67 breast tumors and 22 endometrial carcinomas. Estrogen receptors (ER) were also measured in all samples and progesterone receptors (PR) were analyzed in 57 breast samples and 21 endometrial tumors. A high level of EGFR expression is found in both breast and endometrial carcinomas, although the incidence of EGFR content is greater in breast carcinomas. 36% of breast tumors had EGFR at levels 3-49.5 fmol/mg membrane protein, whereas this percentage of positivity was 27% for endometrial tumors. In 51% of breast carcinoma and 73% of endometrial tumors, there was a positive ER content, whereas 53% of breast tumors and 62% of endometrial carcinomas were positive. A clear inverse relationship between EGFR content and ER and PR status has been observed in breast tumors. Our data confirm the previously described inverse correlation between expression of EGFR and estrogen receptors in human breast cancer. We also show here that there is a similar inverse relationship between EGFR content and ER levels in endometrial tumors.
Llorens
M A
MA
Servicio de Endocrinología, Metabolismo y Nutrición, Hospital Universitario San Carlos, Madrid, Spain.
Bermejo
M J
MJ
Salcedo
M C
MC
Charro
A L
AL
Puente
M
M
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000032:analysis* / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D066246:ErbB Receptors / Q000032:analysis* / Q000378:metabolism; D005260:Female; D006801:Humans; D007700:Kinetics; D009362:Neoplasm Metastasis; D011980:Receptors, Progesterone / Q000032:analysis; D014594:Uterine Neoplasms / Q000032:analysis* / Q000378:metabolism
D014408:Biomarkers, Tumor; D011980:Receptors, Progesterone; D066246:ErbB Receptors